Kedrion's Plasma Treatment Receives Orphan Drug Designation from EMA Kedrion's treatment for aceruloplasminemia has received Orphan Drug Designation from EMA, marking a significant advance for rare disease therapies.

Kedrion's Plasma Treatment Receives Orphan Drug Designation from EMA #Italy #Orphan_Drug #Castelvecchio_Pascoli #Kedrion #Aceruloplasminemia

Kedrion's Plasma-Derived Treatment Receives Orphan Drug Designation for Rare Genetic Disorder Kedrion's innovative plasma-derived therapy has been given Orphan Drug Designation by the EMA, targeting a rare genetic condition known as Aceruloplasminemia.

Kedrion's Plasma-Derived Treatment Receives Orphan Drug Designation for Rare Genetic Disorder #Italy #EMA #Castelvecchio_Pascoli #Kedrion #Aceruloplasminemia

Kedrion Receives Orphan Drug Designation for Rare Genetic Disorder Treatment Kedrion's innovative plasma-derived treatment for Congenital Aceruloplasminemia has received Orphan Drug Designation from EMA, highlighting a pivotal advancement for patients.

Kedrion Receives Orphan Drug Designation for Rare Genetic Disorder Treatment #Orphan_Drug #Kedrion #Aceruloplasminemia

Kedrion's Commitment to Innovation and Patient Care at IPIC 2025 Kedrion Biopharma participates in IPIC 2025 focusing on secondary immunodeficiencies. The event offers insights into cutting-edge therapeutic advancements.

Kedrion's Commitment to Innovation and Patient Care at IPIC 2025 #Italy #Castelvecchio_Pascoli #Kedrion #Immunodeficiencies #IPIC_2025

Kedrion Achieves FDA Orphan Drug Designation for Rare Disease Treatment Kedrion has announced that the FDA granted Orphan Drug Designation for its investigational treatment addressing Congenital Aceruloplasminemia, a rare genetic condition.

Kedrion Achieves FDA Orphan Drug Designation for Rare Disease Treatment #United_States #FDA #Fort_Lee #Kedrion #Aceruloplasminemia

Kedrion Biopharma Highlights the Importance of Awareness for Plasminogen Deficiency Kedrion Biopharma is actively promoting awareness of Plasminogen Deficiency through diverse virtual and in-person events aimed at educating the public about this rare genetic disorder.

Kedrion Biopharma Highlights the Importance of Awareness for Plasminogen Deficiency #USA #Fort_Lee #PLGD-1 #Kedrion #Plasminogen_Deficiency

Vieni con noi alla scoperta del mondo dei #plasmaderivati! Ti portiamo a fare un tour dello stabilimento produttivo di #Kedrion in provincia di Lucca 🩸

youtu.be/Gp4V3R0h-u0